Monogram Orthopaedics Common Stock Current Liabilities
MGRM Stock | 2.61 0.05 1.88% |
Monogram Orthopaedics Common fundamentals help investors to digest information that contributes to Monogram Orthopaedics' financial success or failures. It also enables traders to predict the movement of Monogram Stock. The fundamental analysis module provides a way to measure Monogram Orthopaedics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Monogram Orthopaedics stock.
As of the 30th of December 2024, Total Current Liabilities is likely to grow to about 4 M, while Non Current Liabilities Total is likely to drop about 274 K. Monogram | Current Liabilities |
Monogram Orthopaedics Common Company Current Liabilities Analysis
Monogram Orthopaedics' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Monogram Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Monogram Orthopaedics is extremely important. It helps to project a fair market value of Monogram Stock properly, considering its historical fundamentals such as Current Liabilities. Since Monogram Orthopaedics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Monogram Orthopaedics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Monogram Orthopaedics' interrelated accounts and indicators.
Click cells to compare fundamentals
Monogram Current Liabilities Historical Pattern
Today, most investors in Monogram Orthopaedics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Monogram Orthopaedics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Monogram Orthopaedics current liabilities as a starting point in their analysis.
Monogram Orthopaedics Current Liabilities |
Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
Monogram Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Monogram Orthopaedics Common has a Current Liabilities of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Monogram Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Monogram Orthopaedics' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Monogram Orthopaedics could also be used in its relative valuation, which is a method of valuing Monogram Orthopaedics by comparing valuation metrics of similar companies.Monogram Orthopaedics is currently under evaluation in current liabilities category among its peers.
Monogram Orthopaedics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Monogram Orthopaedics from analyzing Monogram Orthopaedics' financial statements. These drivers represent accounts that assess Monogram Orthopaedics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Monogram Orthopaedics' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Enterprise Value | 343.5M | 338.3M | 338.4M | 333.9M | 64.0M | 60.8M |
Monogram Orthopaedics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Monogram Orthopaedics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Monogram Orthopaedics' managers, analysts, and investors.Environmental | Governance | Social |
Monogram Fundamentals
Return On Equity | -1.22 | ||||
Return On Asset | -0.61 | ||||
Operating Margin | (40.76) % | ||||
Current Valuation | 73.39 M | ||||
Shares Outstanding | 34.31 M | ||||
Shares Owned By Insiders | 34.22 % | ||||
Shares Owned By Institutions | 3.84 % | ||||
Number Of Shares Shorted | 225.62 K | ||||
Price To Book | 5.14 X | ||||
Price To Sales | 245.36 X | ||||
Revenue | 365 K | ||||
EBITDA | (16.86 M) | ||||
Net Income | (13.75 M) | ||||
Total Debt | 491.99 K | ||||
Book Value Per Share | 0.43 X | ||||
Cash Flow From Operations | (13.54 M) | ||||
Short Ratio | 3.00 X | ||||
Earnings Per Share | (0.47) X | ||||
Target Price | 5.0 | ||||
Number Of Employees | 28 | ||||
Market Capitalization | 89.56 M | ||||
Total Asset | 16.58 M | ||||
Retained Earnings | (51.51 M) | ||||
Working Capital | 11.8 M | ||||
Net Asset | 16.58 M |
About Monogram Orthopaedics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Monogram Orthopaedics Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Monogram Orthopaedics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Monogram Orthopaedics Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Monogram Orthopaedics Piotroski F Score and Monogram Orthopaedics Altman Z Score analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.012 | Return On Assets (0.61) | Return On Equity (1.22) |
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.